Financial Gravity Asset Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.91M Buy
51,858
+5,838
+13% +$277K 0.34% 68
2025
Q4
$2.34M Buy
46,020
+7,132
+18% +$365K 0.45% 58
2025
Q3
$2.16M Buy
+38,888
New +$2.28M 0.43% 56
2025
Q1
$1.79M Buy
+25,730
New +$2.13M 0.39% 64
2024
Q2
$3.34M Sell
23,382
-127
-0.5% -$16.8K 0.83% 28
2024
Q1
$2.43M Sell
23,509
-2
-0% -$238 0.68% 32
2023
Q4
$2.43M Buy
+23,511
New +$2.33M 0.68% 32
2021
Q3
$731K Sell
13,372
-16,752
-56% -$810K 0.34% 54
2021
Q2
$1.35M Buy
+30,124
New +$1.17M 0.48% 47
2020
Q4
$532K Buy
+15,264
New +$528K 0.49% 60
2019
Q4
$58K Buy
208
+32
+18% +$886 0.04% 562
2019
Q3
$5K Sell
176
-48
-21% -$1.21K ﹤0.01% 703
2019
Q2
$6K Sell
224
-170
-43% -$4.2K ﹤0.01% 663
2019
Q1
$10K Buy
+394
New +$9.68K 0.01% 556
2018
Q3
$4K Sell
208
-14
-6% -$342 ﹤0.01% 788
2018
Q2
$5K Sell
222
-16
-7% -$380 ﹤0.01% 765
2018
Q1
$6K Buy
+238
New +$6.25K 0.01% 682

Other funds holding NVO

Financial Gravity Asset Management's NVO Position: Q1 2026 in Review

Financial Gravity Asset Management increased its Novo Nordisk (NVO) stake by 13% in Q1 2026, buying an estimated $277K and bringing the position to 51,858 shares worth $1.91M. The position accounts for 0.34% of the portfolio, ranked #68.

Financial Gravity Asset Management first reported a position in NVO in Q1 2018 and has held it in 17 quarters since. The position peaked at $3.34M in Q2 2024. 1,278 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Financial Gravity Asset Management held 51,858 shares of Novo Nordisk worth $1.91M as of Q1 2026.
  • Financial Gravity Asset Management bought 5,838 Novo Nordisk shares in Q1 2026, an estimated $277K.
  • Novo Nordisk made up 0.34% of Financial Gravity Asset Management's portfolio in Q1 2026, its #68 holding.
  • Financial Gravity Asset Management first reported a position in Novo Nordisk in Q1 2018 and has held it in 17 quarters since.
  • Financial Gravity Asset Management's Novo Nordisk position peaked at $3.34M in Q2 2024.
  • 1,278 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Financial Gravity Asset Management's 13F filing for Q1 2026, filed 8 May 2026.